0.0002USD-60.00%Mkt Cap: 974 USDP/E: —Last update: 2026-05-22
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosc…
Industry Peers
Shell Companiesloading…
Indicators:|
Key Statistics
Company
Market Cap974 USD
Enterprise Value-1.44M USD
Revenue (TTM)—
Gross Profit-28.53M USD
Net Income (TTM)-39.65M USD
Revenue/Share—
Last Price0.0002 USD
Fiscal Year EndDec 2022
MR QuarterDec 2022
Employees8
CountryUS
SectorFinancial Services
IndustryShell Companies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.03
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-6.62
EPS (Forward)-1.35
52W Range
0.00013% of range0.0037
52W High0.0037 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-194.44%
ROA-138.27%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-43.61M USD
CapEx (TTM)133.00K USD
FCF Margin—
FCF Yield-2892633.47%
Net Debt-23.79M USD
Net Debt/EBITDA0.57
Balance Sheet
Debt/Equity0.08
Current Ratio3.60
Quick Ratio3.44
Book Value/Sh-0.4010 USD
Cash/Share5.223 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 15, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.87M
Float4.83M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.8d
Short % Float8.92%
Short % Out.8.57%
Shares Short417.28K
Short (prev mo.)148.51K
Technical
SMA 500.0003 (-27.5%)
SMA 2000.0003 (-30.3%)
Beta-1.07
S&P 52W Chg28.31%
Avg Vol (30d)663
Avg Vol (10d)456
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—